CompletedPhase 2NCT01802502
Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
Studying OBSOLETE: Tuberculous meningitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universitas Padjadjaran
- Principal Investigator
- Rovina Ruslami, M.D., PhDFaculty of Medicine Universitas Padjadjaran - Dr. Hasan Sadikin Hospital Bandung
- Intervention
- Rifampicin intravenous(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2013 – 2014
Study locations (1)
- Hasan Sadikin Hospital, Bandung, West Java, Indonesia
Collaborators
Radboud University Medical Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01802502 on ClinicalTrials.govOther trials for OBSOLETE: Tuberculous meningitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT05383742Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous MeningitisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT05590455Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitisANRS, Emerging Infectious Diseases